Exodus Point Capital Management, LP G1 Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.2 - $4.98 $171,232 - $387,608	77,833 Added 394.15%	97,580 $222,000
Q1 2024 May 14, 2024	BUY	$2.1 - $4.83 $41,468 - $95,378	19,747 New	19,747 $85,000
Q4 2022 Feb 13, 2023	SELL	$5.19 - $13.5 $337,775 - $878,607	-65,082 Reduced 82.45%	13,856 $75,000
Q3 2022 Nov 10, 2022	BUY	$5.17 - $16.99 $350,887 - $1.15 Million	67,870 Added 613.21%	78,938 $986,000
Q2 2022 Aug 19, 2022	SELL	$4.04 - $8.51 $61,161 - $128,832	-15,139 Reduced 57.77%	11,068 $55,000
Q1 2022 May 13, 2022	BUY	$7.6 - $11.02 $31,920 - $46,284	4,200 Added 19.08%	26,207 $199,000
Q4 2021 Feb 11, 2022	SELL	$10.16 - $16.17 $133,776 - $212,910	-13,167 Reduced 37.43%	22,007 $225,000
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $462,889 - $790,359	35,174 New	35,174 $472,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $519,752 - $963,523	-29,565 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$10.99 - $20.4 $180,203 - $334,498	-16,397 Reduced 35.68%	29,565 $532,000
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $139,466 - $286,781	12,075 Added 35.63%	45,962 $531,000
Q2 2020 Aug 14, 2020	BUY	$9.57 - $24.37 $324,298 - $825,826	33,887 New	33,887 $822,000
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $187,879 - $283,557	-9,147 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $208,368 - $371,185	9,147 New	9,147 $208,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.